文献速递肾小球疾病慢性肾脏病

老年IgA肾病

IgA Nephropathy in the Elderly.
PubMed 文献 · Kidney Int Rep · 2025-05-21

该研究纳入1996至2020年本中心诊断时年龄≥60岁的IgA肾病患者127例,中位eGFR为25 ml/min per 1.73 m2,81%患者蛋白尿≥1000 mg/g肌酐,35%和17%分别为CKD 4期和5期。中位至肾衰竭时间为11.3年,至死亡时间为7.5年。肾衰竭与CKD 3、4、5期(相比1或2期)强相关,死亡与年龄增长和晚期CKD相关。

要点

  • 诊断时年龄≥60岁的IgA肾病患者临床表型重,中位eGFR仅25 ml/min per 1.73 m2。
  • 中位至肾衰竭时间11.3年,至死亡时间7.5年。
  • 肾衰竭与CKD 3、4、5期(相比1或2期)强相关,调整组织学后不变。

核心结论

  • 老年诊断的IgA肾病与严重临床表型相关,因肾衰竭和死亡风险高而预示不良预后。

研究设计与样本

  • 研究为在1996年至2020年本中心识别诊断时年龄≥60岁的IgA肾病患者,共127例。
  • 收集年龄、性别、种族、CKD分期和活检时MEST-C组织学分类。
  • 肾衰竭和死亡结局分别通过美国肾脏数据系统(USRDS)和国家死亡索引(NDI)确定。
  • 肾衰竭关联采用原因特异性Cox hazards回归,以全因死亡为竞争风险;全因死亡采用标准Cox比例风险回归;累积生存概率采用Kaplan-Meier生存曲线。

主要发现

  • 127例患者中,中位eGFR为25 ml/min per 1.73 m2,81%有蛋白尿≥1000 mg/g肌酐,35%和17%分别为CKD 4期和5期。
  • 45例进展至肾衰竭,86例死亡;Kaplan-Meier估计中位至肾衰竭时间11.3年,至死亡时间7.5年。
  • 男性较女性更可能进展至肾衰竭。
  • 肾衰竭与CKD 3、4、5期(相比1或2期)强相关,调整组织学后结果不变。
  • 死亡与年龄增长和晚期CKD相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Knowledge about IgA nephropathy (IgAN) presentation and prognosis for elderly patients is limited. We assessed clinical and histologic findings among patients aged ≥ 60 years at diagnosis and examined factors associated with the risk of kidney failure and death. METHODS: We identified those patients at our center between 1996 and 2020. Age, sex, race, chronic kidney disease (CKD) stage, and histologic MEST-C classification at biopsy were collected. Outcomes of kidney failure and death were ascertained by using United States Renal Data System (USRDS) and National Death Index (NDI), respectively. Associations of baseline predictors with kidney failure were examined by using cause-specific Cox hazards regression with all-cause mortality as competing risk. For all-cause mortality, standard Cox proportional hazards regression analysis was used. Cumulative survival probabilities were examined using Kaplan-Meier survival curves. RESULTS: Among 127 patients, median estimated glomerular filtration rate (eGFR) was 25 ml/min per 1.73 m2, 81% had proteinuria ≥ 1000 mg/g creatinine, 35% and 17% had CKD stages 4 and 5, respectively. Forty-five patients progressed to kidney failure and 86 died. Overall, Kaplan-Meier estimate of median time to kidney failure was 11.3 years and to death was 7.5 years. Males were more likely to progress to kidney failure than females. Kidney failure strongly associated with CKD stages 3, 4, and 5 versus stages 1 or 2; findings remained unchanged after adjusting for histology. Mortality was associated with increasing age and advanced CKD. CONCLUSION: IgAN diagnosed at elderly age is associated with severe clinical phenotype and portends a poor prognosis because of high risk of kidney failure and death.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Rizk DV, Dryer E, Tamhane A, et al. IgA Nephropathy in the Elderly. Kidney Int Rep. 2025. PMID: 40814614. doi:10.1016/j.ekir.2025.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。